128 related articles for article (PubMed ID: 12381455)
1. Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study.
Gulyás B; Vas A; Halldin C; Sóvágó J; Sandell J; Olsson H; Fredriksson A; Stone-Elander S; Farde L
Nucl Med Biol; 2002 Oct; 29(7):753-9. PubMed ID: 12381455
[TBL] [Abstract][Full Text] [Related]
2. [Human positron emission tomography with oral 11C-vinpocetine].
Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B
Orv Hetil; 2003 Nov; 144(46):2271-6. PubMed ID: 14702922
[TBL] [Abstract][Full Text] [Related]
3. Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey.
Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöck P; Paróczai M; Farde L
J Neuroimaging; 1999 Oct; 9(4):217-22. PubMed ID: 10540601
[TBL] [Abstract][Full Text] [Related]
4. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.
Gulyás B; Halldin C; Sandell J; Karlsson P; Sóvágó J; Kárpáti E; Kiss B; Vas A; Cselényi Z; Farde L
Acta Neurol Scand; 2002 Dec; 106(6):325-32. PubMed ID: 12460136
[TBL] [Abstract][Full Text] [Related]
5. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.
Gulyás B; Halldin C; Sóvágó J; Sandell J; Cselényi Z; Vas A; Kiss B; Kárpáti E; Farde L
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1031-8. PubMed ID: 12173017
[TBL] [Abstract][Full Text] [Related]
6. [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].
Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöczk P; Farde L
Orv Hetil; 1999 Jul; 140(30):1687-91. PubMed ID: 10461449
[TBL] [Abstract][Full Text] [Related]
7. [Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study].
Vas A; Sóvágó J; Halldin C; Sandell J; Karlsson P; Kárpáti E; Kiss B; Cselényi Z; Farde L; Gulyás B
Orv Hetil; 2002 Nov; 143(47):2631-6. PubMed ID: 12532649
[TBL] [Abstract][Full Text] [Related]
8. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.
Vas A; Gulyás B; Szabó Z; Bönöczk P; Csiba L; Kiss B; Kárpáti E; Pánczél G; Nagy Z
J Neurol Sci; 2002 Nov; 203-204():259-62. PubMed ID: 12417394
[TBL] [Abstract][Full Text] [Related]
9. [11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies.
Gulyás B; Halldin C; Vas A; Banati RB; Shchukin E; Finnema S; Tarkainen J; Tihanyi K; Szilágyi G; Farde L
J Neurol Sci; 2005 Mar; 229-230():219-23. PubMed ID: 15760643
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
[TBL] [Abstract][Full Text] [Related]
11. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
[TBL] [Abstract][Full Text] [Related]
12. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.
Vas A; Shchukin Y; Karrenbauer VD; Cselényi Z; Kostulas K; Hillert J; Savic I; Takano A; Halldin C; Gulyás B
J Neurol Sci; 2008 Jan; 264(1-2):9-17. PubMed ID: 17727889
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of [
Nag S; Krasikova R; Airaksinen AJ; Arakawa R; Petukhovd M; Gulyas B
Bioorg Med Chem Lett; 2019 Aug; 29(16):2270-2274. PubMed ID: 31257082
[TBL] [Abstract][Full Text] [Related]
14. Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetine.
Gulyas B; Toth M; Vas A; Shchukin E; Kostulas K; Hillert J; Halldin C
Curr Radiopharm; 2012 Jan; 5(1):19-28. PubMed ID: 22074478
[TBL] [Abstract][Full Text] [Related]
15. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.
Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C
Neuroimage; 2011 Jun; 56(3):1111-21. PubMed ID: 21320609
[TBL] [Abstract][Full Text] [Related]
16. In vivo biodistribution of [N-11C-methyl]KF 17837 using 3-D-PET: evaluation as a ligand for the study of adenosine A2A receptors.
Stone-Elander S; Thorell JO; Eriksson L; Fredholm BB; Ingvar M
Nucl Med Biol; 1997 Feb; 24(2):187-91. PubMed ID: 9089711
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic evaluation of [11C]vinpocetine binding in the human postmortem brain.
Hall H; Varnäs K; Sandell J; Halldin C; Farde L; Vas A; Kárpáti E; Gulyás B
Acta Biol Hung; 2002; 53(1-2):59-66. PubMed ID: 12064779
[TBL] [Abstract][Full Text] [Related]
19. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Ginovart N; Luthra SK; Bench CJ; Grasby PM; Wikström H; Barf T; Cliffe IA; Fletcher A; Farde L
Nucl Med Biol; 1996 Jul; 23(5):627-34. PubMed ID: 8905828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
